Aspire Biopharma Holdings Inc Sustainability Reports

Aspire Biopharma Holdings, Inc. operates as an early-stage biopharmaceutical technology company developing and marketing disruptive sublingual drug delivery technologies. Its proprietary platform bypasses the gastrointestinal tract to enable rapid absorption of medicines, nutraceuticals, and supplements directly into the bloodstream.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 529900UC0AFER5IEH285

No reports are currently available in our catalogue.